Co-expression networks revealed potential core lncRNAs in the triple-negative breast cancer

被引:40
|
作者
Yang, Fan [1 ]
Liu, Ye-huan [1 ]
Dong, Si-yang [1 ]
Yao, Zhi-han [1 ]
Lv, Lin [1 ]
Ma, Rui-min [1 ]
Dai, Xuan-xuan [1 ]
Wang, Jiao [2 ]
Zhang, Xiao-hua [1 ]
Wang, Ou-chen [1 ]
机构
[1] Wenzhou Med Univ, Dept Surg Oncol, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China
[2] Wenzhou Med Univ, Hosp Eye, Wenzhou, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Triple-negative breast cancer; Long non-coding RNA; RMST; Expression profile; LONG NONCODING RNAS; TRANSCRIPTOME ANALYSIS; IDENTIFICATION; EXPRESSION; SUBTYPES;
D O I
10.1016/j.gene.2016.07.002
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Triple-negative breast cancer (TNBC) is an aggressive type of breast cancer with unfavorable outcome. It is urgent to explore novel biomarkers and potential therapeutic targets in this malignancy. Increasing knowledge of long noncoding RNAs (lncRNAs) significantly deepens our understanding of cancer biology. Here, we sequenced eight paired TNBC tumor tissues and non-cancerous tissues, and validated significantly differentially expressed IncRNAs. Gene ontology (GO) and pathway analysis were used to investigate the function of differentially expressed mRNAs. Further, potential core lncRNAs in TNBC were identified by co-expression networks. Kaplan-Meier analysis also indicated that breast cancer patients with lower expression level of rhabdomyosarcoma 2 associated transcript (RMST), one of the potential core IncRNAs, had worse overall survival. To the best of our knowledge, it was the first report that RMST was involved in breast cancer. Our research provided a rich resource to the research community for further investigating lncRNAs functions and identifying lncRNAs with diagnostic and therapeutic potentials in TNBC. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:471 / 477
页数:7
相关论文
共 50 条
  • [1] The analysis of gene co-expression network and immune infiltration revealed biomarkers between triple-negative and non-triple negative breast cancer
    Yi, Yao
    Zhong, Yu
    Xie, Lianhua
    Lu, Shuxian
    Zhang, Yifeng
    FRONTIERS IN GENETICS, 2025, 15
  • [2] Screening of Key Genes for Triple-Negative Breast Cancer Based on a Differential Co-expression Method
    Yang, Jun
    Guo, Ling
    Su, Yongqi
    Zhang, Yada
    2022 41ST CHINESE CONTROL CONFERENCE (CCC), 2022, : 5729 - 5734
  • [3] Prognostic genes of triple-negative breast cancer identified by weighted gene co-expression network analysis
    Bao, Ligang
    Guo, Ting
    Wang, Ji
    Zhang, Kai
    Bao, Maode
    ONCOLOGY LETTERS, 2020, 19 (01) : 127 - 138
  • [4] Gene and lncRNA co-expression network analysis reveals novel ceRNA network for triple-negative breast cancer
    Le, Kehao
    Guo, Hui
    Zhang, Qiulei
    Huang, Xiaojuan
    Xu, Ming
    Huang, Ziwei
    Yi, Pengfei
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [5] Gene and lncRNA co-expression network analysis reveals novel ceRNA network for triple-negative breast cancer
    Kehao Le
    Hui Guo
    Qiulei Zhang
    Xiaojuan Huang
    Ming Xu
    Ziwei Huang
    Pengfei Yi
    Scientific Reports, 9
  • [6] Novel key genes in triple-negative breast cancer identified by weighted gene co-expression network analysis
    Chen, Jian
    Qian, Xiaojun
    He, Yifu
    Han, Xinghua
    Pan, Yueyin
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (10) : 16900 - 16912
  • [7] Advances in Pathophysiology of Triple-Negative Breast Cancer: The Potential of lncRNAs for Clinical Diagnosis, Treatment, and Prognostic Monitoring
    Zhou, Yangkun
    Yue, Yang
    Fan, Siyu
    Jia, Qiaojun
    Ding, Xianfeng
    MOLECULAR BIOTECHNOLOGY, 2021, 63 (12) : 1093 - 1102
  • [8] Advances in Pathophysiology of Triple-Negative Breast Cancer: The Potential of lncRNAs for Clinical Diagnosis, Treatment, and Prognostic Monitoring
    Yangkun Zhou
    Yang Yue
    Siyu Fan
    Qiaojun Jia
    Xianfeng Ding
    Molecular Biotechnology, 2021, 63 : 1093 - 1102
  • [9] RNF8-CDH1 Co-Expression Predicts Clinical Benefit of Chemoradiotherapy in Triple-Negative Breast Cancer
    Kao, Chieh-Ni
    Moi, Sin-Hua
    Hou, Ming-Feng
    Luo, Chi-Wen
    Chen, Fang-Ming
    Pan, Mei-Ren
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (07):
  • [10] Co-Expression of Androgen Receptor and Cathepsin D Defines a Triple-Negative Breast Cancer Subgroup with Poorer Overall Survival
    Mansouri, Hanane
    Alcaraz, Lindsay B.
    Mollevi, Caroline
    Mallavialle, Aude
    Jacot, William
    Boissiere-Michot, Florence
    Simony-Lafontaine, Joelle
    Laurent-Matha, Valerie
    Roger, Pascal
    Liaudet-Coopman, Emmanuelle
    Guiu, Severine
    CANCERS, 2020, 12 (05)